Wuxi Biologics (Cayman)(HK:2269)
HK$48.880.00 (0.00%)
HK:2269
Wuxi Biologics (Cayman) financials statements
HK$48.88
At close:0.00 (0.00%)
Want to see HK:2269 full AI Analyst Report?
Wuxi Biologics (Cayman) (2269) Income Statement
59 Followers
Wuxi Biologics (Cayman) Income Statement
Last quarter (Q2 2026), Wuxi Biologics (Cayman)'s total revenue was ¥11.79B, an increase of 37.47% from the same quarter last year. In Q2, Wuxi Biologics (Cayman)'s net income was ¥2.44B. See Wuxi Biologics (Cayman)’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 21.79B | ¥ 18.68B | ¥ 17.03B | ¥ 15.27B | ¥ 10.29B | |
| ¥ 10.02B | ¥ 7.65B | ¥ 6.83B | ¥ 6.72B | ¥ 4.83B | |
| ¥ 3.38B | ¥ 2.68B | ¥ 2.38B | ¥ 2.38B | ¥ 1.64B | |
| Depreciation and Amortization | ¥ 1.72B | ¥ 1.44B | ¥ 1.17B | ¥ 800.67M | ¥ 481.78M |
| ¥ 8.37B | ¥ 6.43B | ¥ 5.50B | ¥ 6.22B | ¥ 4.51B | |
| ¥ 6.64B | ¥ 4.97B | ¥ 4.45B | ¥ 4.34B | ¥ 3.19B | |
| ¥ 617.16M | ¥ -139.41M | ¥ -276.39M | ¥ 1.02B | ¥ 805.01M | |
| ¥ 7.26B | ¥ 4.83B | ¥ 4.17B | ¥ 5.36B | ¥ 3.99B | |
| ¥ 4.91B | ¥ 3.36B | ¥ 3.40B | ¥ 4.42B | ¥ 3.39B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 1.16 | ¥ 0.82 | ¥ 0.82 | ¥ 1.06 | ¥ 0.81 |
| Diluted EPS | ¥ 1.16 | ¥ 0.78 | ¥ 0.77 | ¥ 1.01 | ¥ 0.77 |
| Weighted Average Shares Outstanding | 4.18B | 4.08B | 4.16B | 4.17B | 4.40B |
| Weighted Average Shares Outstanding (Diluted) | 4.18B | 4.23B | 4.35B | 4.38B | 4.42B |
Currency in CNY
